Direct retrovirus-mediated gene transfer to the synovium of the rabbit knee: Implications for arthritis gene therapy

S. C. Ghivizzani, E. R. Lechman, C. Tio, K. M. Mule, S. Chada, J. E. McCormack, Christopher H Evans, P. D. Robbins

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

We have investigated the feasibility of using high-titer murine leukemia virus-based retroviral vectors to deliver exogenous genes to naive and chronically inflamed knee joints of rabbits in vivo. Intraarticular injection of retrovirus encoding β-galactosidase (β-gal or lacZ) was found to transduce synoviocytes in both naive and inflamed joints, but a significantly higher number of lacZ+ cells were found in inflamed knees. Using a retrovirus encoding a secretable marker, human growth hormone (hGH), quantitative comparison of ex vivo gene delivery methods demonstrated that transgene expression following in vivo gene transfer was at least equivalent to that of the ex vivo method in inflamed knees. In addition, hGH transgene expression was maintained for at least 4 weeks. These experiments suggest that high-titer retroviral vector could be used for efficient in vivo gene transfer to inflamed joints in patients with rheumatoid arthritis (RA).

Original languageEnglish (US)
Pages (from-to)977-982
Number of pages6
JournalGene Therapy
Volume4
Issue number9
StatePublished - 1997
Externally publishedYes

Fingerprint

Synovial Membrane
Retroviridae
Genetic Therapy
Arthritis
Knee
Rabbits
Human Growth Hormone
Transgenes
Genes
Joints
Galactosidases
Intra-Articular Injections
Murine Leukemia Viruses
Knee Joint
Rheumatoid Arthritis
Cell Count

Keywords

  • In vivo gene delivery
  • Retroviral vectors
  • Rheumatoid arthritis
  • Synovium

ASJC Scopus subject areas

  • Genetics

Cite this

Ghivizzani, S. C., Lechman, E. R., Tio, C., Mule, K. M., Chada, S., McCormack, J. E., ... Robbins, P. D. (1997). Direct retrovirus-mediated gene transfer to the synovium of the rabbit knee: Implications for arthritis gene therapy. Gene Therapy, 4(9), 977-982.

Direct retrovirus-mediated gene transfer to the synovium of the rabbit knee : Implications for arthritis gene therapy. / Ghivizzani, S. C.; Lechman, E. R.; Tio, C.; Mule, K. M.; Chada, S.; McCormack, J. E.; Evans, Christopher H; Robbins, P. D.

In: Gene Therapy, Vol. 4, No. 9, 1997, p. 977-982.

Research output: Contribution to journalArticle

Ghivizzani, SC, Lechman, ER, Tio, C, Mule, KM, Chada, S, McCormack, JE, Evans, CH & Robbins, PD 1997, 'Direct retrovirus-mediated gene transfer to the synovium of the rabbit knee: Implications for arthritis gene therapy', Gene Therapy, vol. 4, no. 9, pp. 977-982.
Ghivizzani SC, Lechman ER, Tio C, Mule KM, Chada S, McCormack JE et al. Direct retrovirus-mediated gene transfer to the synovium of the rabbit knee: Implications for arthritis gene therapy. Gene Therapy. 1997;4(9):977-982.
Ghivizzani, S. C. ; Lechman, E. R. ; Tio, C. ; Mule, K. M. ; Chada, S. ; McCormack, J. E. ; Evans, Christopher H ; Robbins, P. D. / Direct retrovirus-mediated gene transfer to the synovium of the rabbit knee : Implications for arthritis gene therapy. In: Gene Therapy. 1997 ; Vol. 4, No. 9. pp. 977-982.
@article{f11560b977fd4488806dbc832a018019,
title = "Direct retrovirus-mediated gene transfer to the synovium of the rabbit knee: Implications for arthritis gene therapy",
abstract = "We have investigated the feasibility of using high-titer murine leukemia virus-based retroviral vectors to deliver exogenous genes to naive and chronically inflamed knee joints of rabbits in vivo. Intraarticular injection of retrovirus encoding β-galactosidase (β-gal or lacZ) was found to transduce synoviocytes in both naive and inflamed joints, but a significantly higher number of lacZ+ cells were found in inflamed knees. Using a retrovirus encoding a secretable marker, human growth hormone (hGH), quantitative comparison of ex vivo gene delivery methods demonstrated that transgene expression following in vivo gene transfer was at least equivalent to that of the ex vivo method in inflamed knees. In addition, hGH transgene expression was maintained for at least 4 weeks. These experiments suggest that high-titer retroviral vector could be used for efficient in vivo gene transfer to inflamed joints in patients with rheumatoid arthritis (RA).",
keywords = "In vivo gene delivery, Retroviral vectors, Rheumatoid arthritis, Synovium",
author = "Ghivizzani, {S. C.} and Lechman, {E. R.} and C. Tio and Mule, {K. M.} and S. Chada and McCormack, {J. E.} and Evans, {Christopher H} and Robbins, {P. D.}",
year = "1997",
language = "English (US)",
volume = "4",
pages = "977--982",
journal = "Gene Therapy",
issn = "0969-7128",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Direct retrovirus-mediated gene transfer to the synovium of the rabbit knee

T2 - Implications for arthritis gene therapy

AU - Ghivizzani, S. C.

AU - Lechman, E. R.

AU - Tio, C.

AU - Mule, K. M.

AU - Chada, S.

AU - McCormack, J. E.

AU - Evans, Christopher H

AU - Robbins, P. D.

PY - 1997

Y1 - 1997

N2 - We have investigated the feasibility of using high-titer murine leukemia virus-based retroviral vectors to deliver exogenous genes to naive and chronically inflamed knee joints of rabbits in vivo. Intraarticular injection of retrovirus encoding β-galactosidase (β-gal or lacZ) was found to transduce synoviocytes in both naive and inflamed joints, but a significantly higher number of lacZ+ cells were found in inflamed knees. Using a retrovirus encoding a secretable marker, human growth hormone (hGH), quantitative comparison of ex vivo gene delivery methods demonstrated that transgene expression following in vivo gene transfer was at least equivalent to that of the ex vivo method in inflamed knees. In addition, hGH transgene expression was maintained for at least 4 weeks. These experiments suggest that high-titer retroviral vector could be used for efficient in vivo gene transfer to inflamed joints in patients with rheumatoid arthritis (RA).

AB - We have investigated the feasibility of using high-titer murine leukemia virus-based retroviral vectors to deliver exogenous genes to naive and chronically inflamed knee joints of rabbits in vivo. Intraarticular injection of retrovirus encoding β-galactosidase (β-gal or lacZ) was found to transduce synoviocytes in both naive and inflamed joints, but a significantly higher number of lacZ+ cells were found in inflamed knees. Using a retrovirus encoding a secretable marker, human growth hormone (hGH), quantitative comparison of ex vivo gene delivery methods demonstrated that transgene expression following in vivo gene transfer was at least equivalent to that of the ex vivo method in inflamed knees. In addition, hGH transgene expression was maintained for at least 4 weeks. These experiments suggest that high-titer retroviral vector could be used for efficient in vivo gene transfer to inflamed joints in patients with rheumatoid arthritis (RA).

KW - In vivo gene delivery

KW - Retroviral vectors

KW - Rheumatoid arthritis

KW - Synovium

UR - http://www.scopus.com/inward/record.url?scp=0030847418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030847418&partnerID=8YFLogxK

M3 - Article

C2 - 9349435

AN - SCOPUS:0030847418

VL - 4

SP - 977

EP - 982

JO - Gene Therapy

JF - Gene Therapy

SN - 0969-7128

IS - 9

ER -